Takasaki S I, Kasai K I, Ishii S I
J Biochem. 1975 Dec;78(6):1275-85. doi: 10.1093/oxfordjournals.jbchem.a131025.
The interaction of bovine thrombin [EC 3.4.21.5] with synthetic substrates and products was studied. The enzyme was purified from Parke-Davis topical thrombin. The purification process afforded some preparations with different clottin specific activities but with similar esterase specific activities. The preparation having highest clotting specific activity and that having lowest clotting activity were tentatively named thrombin-C and thrombin-E, respectively. Kinetic parameters for the hydrolysis of synthetic substrates and normality titrants were determined on the basis of active enzyme quantity, which was assayed by means of a fluorometric normality titrant. It was shown that thrombin-E was acylated by the substrates more slowly than thrombin-C, while deacylation proceeded at similar rates in the two preparations. The results were also compared with those obtained with bovine trypsin [EC 3.4.21.4]. The acylation rates of both thrombin preparations were markedly lower than that of trypsin, while the deacylation rates of the former were only slightly lower than that of the latter. The effects of various product-type inhibitors, such as benzyloxycarbonyl-, benzoyl-, and tosyl-L-arginine, were also examined. Thrombin was affected by these inhibitors not competitively, though trypsin was inhibited competitively.
研究了牛凝血酶[EC 3.4.21.5]与合成底物及产物的相互作用。该酶从帕尔克-戴维斯局部用凝血酶中纯化得到。纯化过程得到了一些凝血活性比不同但酯酶活性比相似的制剂。凝血活性比最高的制剂和最低的制剂分别暂定为凝血酶-C和凝血酶-E。基于活性酶量测定了合成底物和当量滴定剂水解的动力学参数,活性酶量通过荧光当量滴定剂进行测定。结果表明,凝血酶-E被底物酰化的速度比凝血酶-C慢,而两种制剂中脱酰化的速度相似。还将结果与用牛胰蛋白酶[EC 3.4.21.4]得到的结果进行了比较。两种凝血酶制剂的酰化速度均明显低于胰蛋白酶,而前者的脱酰化速度仅略低于后者。还研究了各种产物型抑制剂,如苄氧羰基-、苯甲酰-和甲苯磺酰-L-精氨酸的作用。这些抑制剂对凝血酶无竞争性影响,而对胰蛋白酶有竞争性抑制作用。